IN FOCUS: August 2025 Newsletter - FUJIFILM Biotechnologies

August 2025 Monthly Insights Newsletter

August 2025 Newsletter FUJIFILM Biotechnologies is proud to be an innovative CDMO partner, seamlessly guiding our customers though their journey of creating life-impacting medicines from initial process development stages through to full commercial supply. Catch up on our latest news and insights below.

New Fujifilm drug plant boosts U.S. biologic manufacturing capacity

CNBC pharma reporter Angelica Peebles recently featured FUJIFILM Biotechnologies in live broadcasts from our new large-scale cell culture manufacturing site in Holly Springs, North Carolina. The feature videos and summary article discuss some of the challenges and opportunities for drug companies that are increasing U.S. manufacturing.

Learn More ›

SOLUTIONS SPOTLIGHT Gene Therapies

Learn about critical steps to optimize viral vector manufacturing Read our Blog →	Our Texas site provides clients with process and analytical development & cGMP manufacturing for viral vectors Explore the site’s capabilities. →	Want to know more about our global gene therapy capabilities? Download our VGT Brochure →

NOW TRENDING

In the News

During the recent Endpoints’ Manufacturing Day. Laurie Braxton, SVP, Head of North Carolina Operations, shared her insights on current challenges and vulnerabilities in the global supply chain and how CDMOs are crucial in ensuring supply chain resilience in an expert panel session titled: “Battling Wildfires in Biopharma Supply Chains: CDMO Leaders Weigh In.“ Watch the Webinar →
Christian Houborg, General Manager & SVP at our Hillerød site in Denmark, recently sat down with Pharma Boardroom to discuss how the site is setting new standards in biomanufacturing and revolutionizing industrialization so that our partners “can focus on discovery and innovation”. Read more →
In a recent BioPharm International article, our innovation and downstream process development experts joined an engaging discussion on the topic “Time-to-Market Pressures Are Influencing Downstream Processing Innovations”. Read more →
Johnson & Johnson continues U.S. investment with $2 billion commitment to enable manufacturing at FUJIFILM’s state-of-the-art facility in Holly Springs, North Carolina. Read more →

Upcoming Events

	Cell & Gene Therapy World Asia 2025 September 10-11 \| Singapore Sara Miller, Director, Advanced Therapies Commercial Technical Lead, will be presenting on the topic: Building Customer Confidence and Reducing Risk with Early Access to Development Teams. Learn More →

	Cell & Gene Therapy Symposium September 10 \| Los Angeles, CA Cindy Colón Santiago, Senior Director of Manufacturing, is joining the panel discussion titled: Manufacturing Innovations – How We Scale Up in an Affordable Way. Learn More →

	BioProcess International US & Cell and Gene Therapy International September 16 \| Boston \| Booth #1624 Sara Miller, Director, Advanced Therapies Commercial Technical Lead, will be giving a keynote plenary session discussing on the topic: Building Customer Confidence and Reducing Risk with Early Access to Development Teams. Learn More →

	Festival of Biologics September 30 \| Basel \| Booth #651 Charlie Heise, Associate Director, Bioprocessing Strategy & Development, will be presenting on the topic: KojoX – A Transformative Operational Ecosystem Delivering Flexible Manufacturing Strategies and Security of Supply. Learn More →

Update Your Email Preferences Want to keep up to date with all the news and service offerings from FUJIFILM Biotechnologies? Let us know more about the information you’re interested in receiving from us by using the link below. Update My Preferences ›

© 2025 FUJIFILM Biotechnologies. All Rights Reserved. Unsubscribe Terms & Conditions Privacy Policy